The drug has reportedly reduced patients' urge to drink, which could mean it could help treat alcoholism.
The maker of Ozempic is planning to investigate a phenomenon surrounding its drug's effect on users' desire to drink alcohol.
The study will instead look into how semaglutide — the active ingredient in Ozempic and other GLP-1 receptor agonists, like Wegovy — and other medicines can improve liver health and reduce alcohol use in people with alcohol-related liver disease. The trial plans to enroll an estimated 240 people with a history of alcohol overuse for five years or more and who have enhanced liver fibrosis.Could popular weight loss drugs treat addiction? Lindsey Theis 8:28 AM, Jun 17, 2023 So far, evidence and other clinical trials on the subject are minimal, but last year, Dr.
"Their brains didn't have as much activity in the reward center compared to the placebo group, so we kind of think that that's a thing of that the brains were more desensitized," Kruse said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug FrenzyI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Bernie Sanders Urges Ozempic Maker Novo Nordisk To Be Fair Over ‘Outrageously Expensive’ U.S. Drug PricesRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Ozempic Maker Plans to Study the Drug’s Effects on Alcohol ConsumptionNovo Nordisk, the maker of Ozempic, says it plans to study how the drug lowers a user's desire to drink alcohol. A trial is slated to begin on Monday, May 20.
Read more »
Ozempic Could Be Good For Your Heart Even If You Don't Lose WeightThe Best in Science News and Amazing Breakthroughs
Read more »
Why Meghan McCain Doesn't 'Want' to Go on OzempicMeghan McCain detailed why she doesn't want to go on weight loss drug Ozempic during the latest episode of her 'Citizen McCain' podcast
Read more »